Comparison of GnRH antagonist cycles with and without oral contraceptive pretreatment in potential poor prognosis patients

Clinical and Experimental Obstetrics and Gynecology

Volumn 33, Issue 3, 2006, Pages 145-147

  Bendikson, K ^a   Milki, A A ^a   Speck Zulak, A ^a   Westphal, L M ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antagonist; IVF; Oral contraceptive pills; Poor responders

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; DESOGESTREL PLUS ETHINYLESTRADIOL; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FERTILIZATION; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; PROGNOSIS; REVIEW;

ADULT; CALIFORNIA; CONTRACEPTIVES, ORAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33750960111     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Al-Mizyen E., Sabatini L., Lower A.M., Wilson C.M., al-Shawaf T., Grudzinskas J.G.: Does pretreatment with progestogen or oral contraceptive pills in low responders followed by the GnRHa flare protocol improve the outcome of IVF-ET?". J. Assist. Reprod. Genet., 2000, 17, 140.
2. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., Bahceci M.: "Addition of GnRH antagonist in cycles of poor responders undergoing IVF". Hum. Reprod., 2000, 15, 2145.
3. Surrey E., Schoolcraft W.: "Evaluating strategies for improving ovarian response to the poor responder undergoing assisted reproductive techniques". Fertil. Steril., 2000, 73, 667.
4. Akman M., Erden H., Tosun S., Bayazit N., Aksoy E., Bahceci M.: "Comparison of agonist flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial". Hum. Reprod., 2001, 16, 868.
5. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L. et al.: "Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)". Fertil. Steril., 2000, 73, 314.
6. Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., Devroey P.: "Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin". Hum. Reprod., 2000, 15, 526.
7. Kovacs P., Barg P., Witt B.: "Hypothalamic-pituitary suppression with oral contraceptives pills does not improve outcome in poor responder patients undergoing in vitro fertilization-embryo transfer cycles". J. Assist. Reprod. Genet., 2001, 18, 391.
8. Patton P., Burry K., Wolf D., Kiessling A., Craemer M.: "The use of oral contraceptives to regulate oocyte retrieval". Fertil. Steril., 1988, 49, 716.
9. Gonen Y., Jacobson W., Casper R.: "Gonadotropin suppression with oral contraceptives before in vitro fertilization". Fertil. Steril., 1990, 53, 282.
10. Biljan M., Mahutte N., Dean N., Hemmings R., Bissonnette F., Tan S.: "Effects of pretreatment with an oral contraceptive on the time required to achieve pituiatary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates". Fertil. Steril., 1998, 70, 1063.
11. Lindheim S.R., Barad D.H., Witt B., Sauer M.V.: "Short-term gonadotropin suppresion with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation". J. Assist. Reprod. Genet., 1996, 13, 745.
12. Fisch B., Royburt M., Pinkas H., Avrech O.M., Goldman G.A., Bar J. et al.: "Augmentation of low ovarian response to superovulation before in vitro fertilization following priming with contraceptive pills". Israel Journal of Medical Sciences, 1996, 52, 1172.
13. Shapiro D.B., Mitchell-Leef D., Carter M., Nagy Z.P.: "Ganirelix acetate use in normal- and poor-prognosis patients and the impact of estradiol patterns". Fertil. Steril., 83, 666.
14. Benadiva C.A., Ben-Rafael Z., Blasco L., Tureck R., Mastroianni L., Flickinger G.L.: "Ovarian response to human menopausal gonadotropin following suppression with oral contraceptives". Fertil. Steril., 1988, 50, 516.